The value of the use of anastrozole as an alternative adjuvant therapy for early breast cancer (EBC) using discrete choice willingness-to-pay (WTP) methodology

被引：0
|
作者：
Wilson, J [1 ]
Burridge, J [1 ]
Gniel, J [1 ]
Maclean, A [1 ]
LeReun, C [1 ]
Adams, J [1 ]
Davey, P [1 ]
机构：
[1] M TAG Australia Pty Ltd, Chatswood, NSW, Australia
来源：
VALUE IN HEALTH | 2004年 / 7卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)65769-5
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：680 / 681
页数：2
相关论文
共 28 条
  • [1] Patient preference for anastrozole as adjuvant hormonal therapy for early breast cancer (EBC) using discrete choice willingness-to-pay (WTP) methodology
    Wilson, J
    Burridge, J
    Gniel, J
    Maclean, A
    LeReun, C
    Adams, J
    Davey, P
    [J]. VALUE IN HEALTH, 2004, 7 (06) : 677 - 678
  • [2] ASSESSING THE WILLINGNESS-TO-PAY (WTP) FOR INTRADERMAL INFLUENZA VACCINATION IN AUSTRALIA USING DISCRETE CHOICE METHODOLOGY
    Adams, J.
    Price, N.
    Mason, G.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A237 - A237
  • [3] UNDERSTANDING WHAT PATIENTS VALUE AND THEIR WILLINGNESS-TO-PAY (WTP) FOR HEMOPHILIA THERAPIESA DISCRETE CHOICE EXPERIMENT
    Chaugule, S.
    Hay, J. W.
    Young, G.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A230 - A231
  • [4] Preference and willingness-to-pay study to assess the value of atomoxetine using discrete choice analysis: UK parents perspective
    Cottrell, S.
    Allen, E.
    Pascoe, K.
    Sullivan, T.
    LeReun, C.
    Brown, J.
    Lorenzo, M.
    Aristides, M.
    [J]. VALUE IN HEALTH, 2007, 10 (03) : A86 - A86
  • [5] Cost-effectiveness of anastrozole versus tamoxifen as adjuvant therapy in early breast cancer (EBC) - a German health economic analysis
    Lux, M. P.
    Benedict, A.
    Buchholz, S.
    Woeckel, A.
    Harbeck, N.
    Kreienberg, R.
    Kaufmann, M.
    Beckmann, M. W.
    Jonat, W.
    Hadji, P.
    Distler, W.
    Raab, G.
    Tesch, H.
    Weyers, G.
    Schneeweiss, A.
    Possinger, K.
    [J]. CANCER RESEARCH, 2009, 69 (02) : 380S - 380S
  • [6] An economic evaluation of anastrozole versus tamoxifen as adjuvant therapy in postmenopausal women with early breast cancer (EBC) from a US healthcare perspective
    Locker, GY
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 24S - 24S
  • [7] USE OF PHARMACOGENETIC TESTING TO DETERMINE ADJUVANT HORMONAL THERAPY CHOICE IN EARLY STAGE BREAST CANCER PATIENTS: A VALUE OF INFORMATION ANALYSIS
    Woods, B. S.
    Hawkins, N. S.
    [J]. VALUE IN HEALTH, 2009, 12 (03) : A4 - A4
  • [8] QALY-type preference and willingness-to-pay among end-of-life patients with cancer treatments: a pilot study using discrete choice experiment
    Yin, Yue
    Peng, Qian
    Ma, Longhao
    Dong, Yi
    Sun, Yinan
    Xu, Silu
    Ding, Nianyang
    Liu, Xiaolin
    Zhao, Mingye
    Tang, Yaqian
    Mei, Zhiqing
    Shao, Hanqiao
    Yan, Dan
    Tang, Wenxi
    [J]. QUALITY OF LIFE RESEARCH, 2024, 33 (03) : 753 - 765
  • [9] QALY-type preference and willingness-to-pay among end-of-life patients with cancer treatments: a pilot study using discrete choice experiment
    Yue Yin
    Qian Peng
    Longhao Ma
    Yi Dong
    Yinan Sun
    Silu Xu
    Nianyang Ding
    Xiaolin Liu
    Mingye Zhao
    Yaqian Tang
    Zhiqing Mei
    Hanqiao Shao
    Dan Yan
    Wenxi Tang
    [J]. Quality of Life Research, 2024, 33 : 753 - 765
  • [10] Cost-effectiveness of anastrozole vs tamoxifen as adjuvant therapy in postmenopausal women with early breast cancer (EBC): A UK National Health Service (NHS) perspective
    Benedict, A
    [J]. VALUE IN HEALTH, 2004, 7 (03) : 221 - 221
123